Surgical treatment of obesity is an option to treat type 2 diabetes in appropriate surgical candidates with BMI (body mass index) ≥40 kg/m2 (BMI ≥37.5 kg/m 2 in Asian Americans) BMI 35 to 39.9 kg/m 2 (BMI 32.5 to 37.4 kg/m 2 in Asian Americans) when hyperglycemia is inadequately controlled by lifestyle measures and optimal medical therapy. However, longer-term follow-up of clinically important endpoints, such as effects on microvascular and macrovascular complications and mortality, are required before bariatric surgery procedures can be routinely recommended for the treatment of persistent hyperglycemia, resistant to multiple medications, in obesity-related type 2 diabetes.
Additional follow-up from a bariatric surgery trial in obese patients with type 2 diabetes (134 patients in a follow-up study, 150 patients in an initial trial) continues to show reduced glycated haemoglobin (A1C)…
